[Neonatal nutrition with enriched human milk. EOPROTIN 60 in comparison with human albumin]

The influence of feeding fresh human milk supplemented either with EOPROTIN (n = 13) or human albumin (n = 15) on biochemical parameters and growth were studied in preterm infants with gestational ages below 32 weeks p.m. up to the 42nd day of postnatal life. In both feeding groups the intakes of protein, energy and electrolytes were similar. The serum concentrations of bile acids, alpha-amino-nitrogen and prealbumin, the renal excretion of total nitrogen, alpha-amino-nitrogen, urea and ammonia as well as the growth in weight and length were studied in all infants. The supplementation of the fresh human milk with EOPROTIN results in significant lower serum concentrations of alpha-amino-nitrogen (1.56 +/- 0.21 vs 2.03 +/- 0.27 mmol/l; p less than 0.01), higher serum concentrations of prealbumin (89.8 +/- 20.3 vs 72.7 +/- 13.3 mg/l; p less than 0.02), and lower urinary excretion of total nitrogen (7.4 +/- 0.9 vs 8.9 +/- 1.1 mmol/kg/day); if compared to the results found in the infants fed human albumin supplemented human milk. The higher nitrogen retention in the EOPROTIN than in the human albumin fed infants was associated by a significant higher growth in weight (16.6 +/- 1.4 vs 13.7 +/- 1.9 g/kg/day; p less than 0.01) as well as in length (1.02 +/- 0.08 vs 0.87 +/- 0.1 cm/week; p less than 0.01). The results indicate that the bioavailability of EOPROTIN is higher than that of human albumin. The observed differences in the nutritional response between the two human milk supplements may be based on differences in the amino acids composition which is in EOPROTIN adapted to the nutritional available part of the protein in human milk.